3.1
76
CMC Development & Regulatory Readiness
Govern CMC development, evidence readiness, and regulatory preparation.
View toolkitStage 3
CMC and investigational product readiness
Controls for developing, manufacturing, testing, releasing and maintaining investigational products.
What this stage covers
CMC strategy, drug substance and product development, analytical methods, release, stability, comparability, and CMO oversight.
How it helps your team: Keep CMC evidence, changes, and release decisions visible as development moves forward.
10 toolkits
Choose the operational area you need
3.2
65
Drug Substance Development & Control Strategy
Define drug substance development, process controls, impurities, CQAs, and CPPs.
View toolkit3.3
65
Drug Product / Formulation Development
Define formulation, excipient, container closure, and drug product control strategy.
View toolkit3.4
65
Analytical Method Development & Validation
Govern analytical methods, validation, transfer, lifecycle, and deviations.
View toolkit3.5
65
Specifications & Release Testing
Manage specifications, release testing, CoAs, OOS/OOT, and justification.
View toolkit3.6
65
Clinical Trial Material Manufacturing & Batch Release
Control CTM manufacture, batch review, release, deviations, and traceability.
View toolkit3.7
65
Stability Program Management
Manage stability protocols, data trends, excursions, shelf-life, and retest justification.
View toolkit3.8
66
IMP Packaging, Labelling & Distribution
Control IMP packaging, labelling, inventory, distribution, custody, and temperature excursions.
View toolkit3.9
64
CMC Change Control & Comparability
Manage CMC changes, comparability, manufacturing impact, and regulatory impact.
View toolkit3.10
65
CMO / Manufacturing Vendor Oversight
Oversee CMOs, manufacturing vendors, audits, KPIs, and tech transfer.
View toolkitNot sure which toolkit fits the work?
Return to the full catalogue and search by process, study, submission or control.